Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Endovascular Treatment for Acute Mild Basilar Artery Occlusion
NCT07390032Not yet recruiting
- Sponsor
- FengGao
- Start
- Mar 2026
- Primary completion
- Dec 2028
- Countries
- 1
01
Overview
Randomised, single-blind trial in basilar artery occlusion (BAO) (2 arms), sponsored by FengGao. Primary endpoint: Modified Rankin Scale score 0-2 at 90 days. Planned start Mar 2026; status: not yet recruiting.
02
Conditions
basilar artery occlusion (BAO)
Beyond the preview
Go deeper on NCT07390032.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT07390032.